Add to your calendar

2018-10-23 14:00:00 2018-10-24 13:30:00 Europe/Madrid Innovation in Breast Cancer 2018 Innovation in Breast Cancer 2018 Auditorio Rafael del Pino, Calle Rafael Calvo, 39A, 28010 Madrid ibc@doctaforum.com
-116days -2Hours -20Minutes -45Seconds

Saturday, February 24th

Home  >>  Saturday, February 24th

Chair:
Agustí Barnadas
Hospital Santa Creu i Sant Pau, Barcelona, Spain
08:30 - 09:00New clinical data on PARP inhibition in patients with breast cancer and
germinal BRCA mutations

Nicholas C. Turner
The Royal Marsden Hospital and Institute of Cancer Research, London, UK
09:00 - 09:30Current status of PI3K-mTOR inhibition studies in hormone-receptor positive
breast cancer

Navid Sobhani
University of Trieste, Italy
09:30 - 10:00Managing everolimus toxicity in breast cancer
Hope Rugo
University of California San Francisco, USA
10:00 - 10:30Predicting response to neoadjuvant therapy in triple negative breast cancer
Miguel Martín
Hospital General Universitario Gregorio Marañón, Madrid, Spain
10:30 - 11:00Discussion
All
Chair:
Miguel Martín
Hospital General Universitario Gregorio Marañón, Madrid, Spain
11:30 - 12:00Adjuvant therapy for HER2-positive early breast cancer: a size fits all?
Antonio Llombart
Hospital Arnau de Vilanova, Valencia, Spain
12:00 - 12:30Chemotherapy-induced alopecia: current advances
Hope Rugo
University of California San Francisco, USA
12:30 - 13:00Should CDK 4/6 inhibitors be used in first or second-line therapy?
Giuseppe Curigliano
Istituto Europeo di Oncologia, Italy
13:00 - 13:30Discussion
All
Miguel Martín
Hospital General Universitario Gregorio Marañón, Madrid, Spain

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies.

ACEPTAR